Company Filing History:
Years Active: 2020-2025
Title: Anqi Zheng: Innovator in HIV-1 Research
Introduction
Anqi Zheng is a notable inventor based in Boyds, MD, who has made significant contributions to the field of HIV-1 research. With a total of two patents to his name, Zheng's work focuses on developing innovative solutions to combat HIV-1 infections.
Latest Patents
Zheng's latest patents include groundbreaking discoveries related to neutralizing antibodies to GP120. These patents disclose antibodies and antigen binding fragments that specifically bind to GP120 and neutralize HIV-1. The patents also provide nucleic acids encoding these antibodies, vectors, and host cells. Furthermore, methods for detecting HIV-1 using these antibodies are outlined. The use of these antibodies, antigen binding fragments, nucleic acids, and vectors to prevent and/or treat HIV-1 infections is also disclosed.
Career Highlights
Anqi Zheng is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. This position allows Zheng to engage in cutting-edge research and contribute to public health initiatives aimed at combating HIV-1.
Collaborations
Zheng collaborates with esteemed colleagues, including Mark Connors and Jinghe Huang, to advance research in the field of HIV-1. These collaborations enhance the potential for innovative solutions and breakthroughs in treatment.
Conclusion
Anqi Zheng's work in developing neutralizing antibodies against HIV-1 represents a significant advancement in medical research. His contributions are vital in the ongoing fight against HIV-1 infections, showcasing the importance of innovation in healthcare.